Examining implementation of the Compounding Quality Act :  hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018. 

 - 1 online resource (vi, 286 pages) :  illustrations 
<br/><br/> "Serial no. 115-96."  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Drug Quality and Security Act. <br/>United States. Food and Drug Administration --Rules and practice.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs--Dosage forms--Government policy--United States.<br/>Pharmaceutical industry--Government policy--United States.<br/>Drug adulteration--Prevention.--United States
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.
<br/><br/><label>LC Class. No.: </label>KF27  / .E553 2018e 
<br/><br/><label>GPO Item No.: </label>1019-C-01 (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.C 73/8:115-96 
<br/><br/><label>Report. No.: </label>Serial no. 115-96 (United States. Congress. House. Committee on Energy and Commerce)